PATIENTS WITH BRCA MUTATIONS HAVE SUPERIOR OUTCOMES AFTER INTRAPERITONEAL CHEMOTHERAPY (IP) IN OPTIMALLY RESECTED HIGH GRADE OVARIAN CANCER (HGOC)

被引：0
|
作者：
Naumann, R. W. [1 ]
Symanowski, J. T. [2 ]
Morris, J. [1 ]
Crane, E. [1 ]
Tait, D. [1 ]
Higgins, R. V. [1 ]
Drury, L. [1 ]
North, L. [1 ]
Brown, J. [1 ]
机构：
[1] Carolinas Med Ctr, Levine Canc Inst, Ob Gyn, Charlotte, NC 28203 USA
[2] Carolinas Med Ctr, Levine Canc Inst, Biostat, Charlotte, NC 28203 USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2018年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS8-1393
引用
收藏
页码：789 / 790
页数：2
相关论文
共 50 条
  • [1] Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer
    Naumann, R. Wendel
    Morris, Jacob C.
    Tait, David L.
    Higgins, Robert V.
    Crane, Erin K.
    Drury, Lane K.
    Amacker-North, Lisa
    Templin, Megan
    Brown, Jubilee
    GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 477 - 480
  • [2] Patient with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected ovarian cancer
    Naumann, R. W.
    Morris, J. C.
    Tait, D. L.
    Higgins, R. V.
    Crane, E. K.
    Drury, L. K.
    Templin, M.
    Brown, J.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 205 - 206
  • [3] A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer
    Suidan, Rudy S.
    Clair, Caryn M. St.
    Lee, Stephen J.
    Barlin, Joyce N.
    Roche, Kara C. Long
    Tanner, Edward J.
    Sonoda, Yukio
    Barakat, Richard R.
    Zivanovic, Oliver
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (03) : 468 - 472
  • [4] Comparison of Primary Intraperitoneal Chemotherapy to Consolidation Intraperitoneal Chemotherapy in Optimally Resected Advanced Ovarian Cancer
    Suidan, Rudy S.
    St Clair, Caryn M.
    Lee, Stephen J.
    Barlin, Joyce N.
    Roche, Kara C. Long
    Tanner, Edward J.
    Sonoda, Yukio
    Barakat, Richard R.
    Zivanovic, Oliver
    Chi, Dennis S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (12) : 741 - 742
  • [5] Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients
    Walker, J. L.
    ANNALS OF ONCOLOGY, 2013, 24 : 41 - 45
  • [6] Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?
    Le, T.
    Latifah, H.
    Jolicoeur, L.
    Weberpals, J.
    Faught, W.
    Hopkins, L.
    Fung, M. Fung Kee
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 451 - 454
  • [7] Is there a survival benefit associated with intraperitoneal chemotherapy after neoadjuvant chemotherapy for optimally debulked epithelial ovarian cancer patients?
    Song, M.
    Vogel, R. Isaksson
    Rivard, C.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 101 - 101
  • [8] BRCA mutations in high grade serous ovarian cancer in Kazakhstan
    Kaidarova, Dilyara
    Bolatbekova, Raikhan
    Naumann, Robert
    Brown, Jubilee
    Kukubassov, Yerlan
    Goncharova, Tatyana
    Orazgaliyeva, Madina
    Aidarov, Askar
    Osikbayeva, Saniya
    Satanova, Alima
    Kaldybekov, Dauren
    Ismailov, Sanzhar
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A169 - A170
  • [9] Oncological outcomes of intraperitoneal chemotherapy in advanced ovarian cancer: BRCA mutation role
    Padilla-Iserte, Pablo
    Ivanez, Maria
    Muruzabal, Juan Carlos
    Navarro, Rafael
    Diaz-Feijoo, Berta
    Iacoponi, Sara
    Garcia-Pineda, Virginia
    Diaz, Cristina
    Utrilla-Layna, Jesus
    Gil-Moreno, Antonio
    Serra, Anna
    Gilabert-Estelles, Juan
    Canto, Cristina Martinez
    Tejerizo, Alvaro
    Lago, Victor
    Cardenas-Rebollo, Jose Miguel
    Domingo, Santiago
    EJSO, 2024, 50 (04):
  • [10] INTRAPERITONEAL CHEMOTHERAPY IN PATIENTS WITH OPTIMALLY DEBULKED OVARIAN CANCER - THE WESTMEAD HOSPITAL EXPERIENCE
    Girgis, C.
    Brand, A.
    Wain, G.
    Hogg, R.
    Harnett, P.
    Lindemann, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 765 - 765
12345